How $737 a Month Could Make You a Millionaire
A seven-figure net worth is in reach in the long run.
Mindfully Curated
A seven-figure net worth is in reach in the long run.
Scientists have figured out how plants respond to light and can flip this genetic switch to encourage food growth, even in shade. The discovery could help increase food supply for an expanding population with shrinking opportunities for farming.
A study including more than 22,000 female nurses in Denmark evaluated exposure over 15-20 years to air pollution and road traffic noise to evaluate the impact on heart failure. Exposure to small particulate matter and road traffic noise over three year…
By decoding honeybees’ waggle dances, which tell other bees where to find food, researchers have found that bees in agricultural areas travel farther for food than those in urban areas.
Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health conditions or vice versa, according to the new findings.
Pullbacks make stocks less expensive, but that doesn’t inherently make them worth owning.
If you’re ready, you can make a lot of money by investing in the stock market.
Google, Facebook, Zoom, Apple, and Peloton should watch their backs.
ITA plans to buy or lease dozens of new planes over the next few years, and they will all be Airbus jets.
SoFi Technologies could soon get a bank charter, but the broader market’s woes seem to have overshadowed this great news.
The restaurant tech company has a lofty valuation.
Can the streaming-TV giant’s subscriber growth reaccelerate after a slow first half of 2021?
These individual stocks offer growth, diversity, and some degree of familiarity.
The social media company faces tough questions about its future.
Affirm is competing in the buy-now, pay-later industry, but its long-term ambitions appear to go well beyond
A drop in the overall market provides an opportunity for investors to pounce.
Here’s one savings plan you don’t want to neglect to sign up for.
Megatrends in technology favor growing demand for Micron’s products.
Merck is ready to apply for authorization ahead of Pfizer.
Are you one of them?